The Plexiform Neurofibroma Microenvironment

被引:18
|
作者
Yang, Feng-Chun [1 ,2 ]
Staser, Karl [1 ,3 ]
Clapp, D. Wade [1 ,3 ,4 ]
机构
[1] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
关键词
NF1; Tumor microenvironment; Mast cells; Neurofibromas;
D O I
10.1007/s12307-012-0115-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dynamic interactions between tumorigenic cells and surrounding cells, including immunomodulatory hematopoietic cells, can dictate tumor initiation, progression, and transformation. Hematopoietic-stromal interactions underpin the plexiform neurofibroma, a debilitating tumor arising in individuals afflicted with Neurofibromatosis type 1 (NF1), a common genetic disorder resulting from mutations in the NF1 tumor suppressor gene. At the tissue level, plexiform neurofibromas demonstrate a complex microenvironment composed of Schwann cells, fibroblasts, perineural cells, mast cells, secreted collagen, and blood vessels. At the cellular level, specific interactions between these cells engender tumor initiation and progression. In this microenvironment hypothesis, tumorigenic Schwann cells secrete pathological concentrations of stem cell factor, which recruit c-kit expressing mast cells. In turn, activated mast cells release inflammatory effectors stimulating the tumorigenic Schwann cells and their supporting fibroblasts and blood vessels, thus promoting tumor expansion in a feed-forward loop. Bone marrow transplantation experiments in plexiform neurofibroma mouse models have shown that tumorigenesis requires Nf1 haploinsufficiency in the hematopoietic compartment, suggesting that tumor microenvironments can depend on intricate interactions at both cellular and genetic levels. Overall, our continued understanding of critical tumor-stromal interactions will illuminate novel therapeutic targets, as shown by the first-ever successful medical treatment of a plexiform neurofibroma by targeted inhibition of the stem cell factor/c-kit axis.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 50 条
  • [21] Challenging Management of Plexiform Schwannoma and Plexiform Neurofibroma
    Nicoli, Taija K.
    Saat, Riste
    Tarkkanen, Jussi
    Kinnunen, Ilpo
    Makitie, Antti A.
    Jero, Jussi
    JOURNAL OF CRANIOFACIAL SURGERY, 2022, 33 (03) : 803 - 808
  • [22] Mast cells are integral components of the tumor microenvironment that are required for plexiform neurofibroma progression.
    Yang, Fengchun
    Ingram, David A.
    Chen, Shi
    Yuan, Jin
    Li, Xiaohong
    Horn, Whitney
    Parada, Luis
    Clapp, D. Wade
    BLOOD, 2006, 108 (11) : 203A - 203A
  • [23] Plexiform Neurofibroma Treated with Pharmacopuncture
    Lim, Chungsan
    Kwon, Kirok
    Lee, Kwangho
    JOURNAL OF PHARMACOPUNCTURE, 2014, 17 (03) : 74 - 77
  • [24] A brief report of plexiform neurofibroma
    Khajavi, Mandi
    Khoshsirat, Shahrokh
    Ahangarnazari, Lida
    Majdinasab, Niloofar
    CURRENT PROBLEMS IN CANCER, 2018, 42 (02) : 256 - 260
  • [25] Plexiform Neurofibroma A Case Report
    Tchernev, Georgi
    Chokoeva, Anastasiya Atanasova
    Patterson, James W.
    Bakardzhiev, Ilko
    Wollina, Uwe
    Tana, Claudio
    MEDICINE, 2016, 95 (06)
  • [26] Plexiform neurofibroma of the sublingual gland
    Kahwaji, G
    Hamdan, AL
    Mufarij, A
    Fuleihan, NS
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (06) : 927 - 927
  • [27] Plexiform neurofibroma of the solar plexus
    Bruce, HA
    BRITISH JOURNAL OF SURGERY, 1924, 12 (46) : 268 - 272
  • [28] Plexiform neurofibroma with intraspinal extension
    van Sandick, JW
    van Coevorden, F
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 195 (04) : 572 - 572
  • [29] PLEXIFORM NEUROFIBROMA OF THE MEDIAN NERVE
    MONBALLIU, G
    CHIRURGIA PLASTICA, 1981, 6 (02): : 141 - 145
  • [30] PLEXIFORM NEUROFIBROMA OF THE LIVER, A HAMARTOMA
    LANE, BP
    PARTIN, JS
    PARTIN, JC
    HEPATOLOGY, 1988, 8 (05) : 1295 - 1295